School of Nursing


Doctor of Nursing Practice (DNP)


Vickie Moore


Herpes Zoster, Immunization, Recombinant Zoster Vaccine, Shingles, Shingrix Vaccination, Vaccine Education


Diseases | Education | Medical Education | Medicine and Health Sciences


Shingles is a prevalent disease within the overall population, and incidence in North America continues to increase. Shingles is commonly found in older adults 60 years of age and older and can recur two or three times. Shingrix was released in 2017 as a recombinant vaccine for prevention of shingles. Despite its benefits, this vaccine has not been recommended by many prescribing providers. Research has shown that an effective education program improves attitudes and misconceptions related to vaccines and can increase prescribing rates. An education program was created to share with prescribing providers to improve overall knowledge and recommendation rates for the vaccine. This formal education program was designed for prescribing providers for review in a 30-minute seminar. To determine overall effectiveness, the program was piloted in a primary care office setting in Central Virginia. The program was found to increase overall knowledge and appeared to increase the likelihood of recommendation. This evidence-based practice project was consistent with established research indicating that when a prescribing provider is informed about a vaccine, he or she is more likely to discuss it with patients. Patients consider their prescribing provider’s opinion seriously when making decisions about vaccines, including Shingrix.